Sangamo Therapeutics (SGMO) Shares Issued (2016 - 2025)
Historic Shares Issued for Sangamo Therapeutics (SGMO) over the last 17 years, with Q3 2025 value amounting to $15.6 million.
- Sangamo Therapeutics' Shares Issued changed N/A to $15.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.1 million, marking a year-over-year increase of 6939.43%. This contributed to the annual value of $21.9 million for FY2024, which is 4470.41% up from last year.
- Per Sangamo Therapeutics' latest filing, its Shares Issued stood at $15.6 million for Q3 2025.
- In the past 5 years, Sangamo Therapeutics' Shares Issued ranged from a high of $22.5 million in Q1 2024 and a low of -$600000.0 during Q2 2024
- Over the past 5 years, Sangamo Therapeutics' median Shares Issued value was $1.4 million (recorded in 2021), while the average stood at $5.0 million.
- In the last 5 years, Sangamo Therapeutics' Shares Issued soared by 3736250.0% in 2023 and then crashed by 11001.0% in 2024.
- Sangamo Therapeutics' Shares Issued (Quarter) stood at $1.1 million in 2021, then crashed by 96.81% to $34000.0 in 2022, then plummeted by 97.06% to $1000.0 in 2023, then tumbled by 6600.0% to -$65000.0 in 2024, then soared by 24121.54% to $15.6 million in 2025.
- Its Shares Issued stands at $15.6 million for Q3 2025, versus $11.2 million for Q2 2025 and $10.4 million for Q1 2025.